BIIB: 渤健

BIIB新闻

• 10:19 Biogen (BIIB) Surges 5.3%: Is This an Indication of Further Gains?
• 13:00 Exelixis (EXEL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
• 11:38 B of A Securities Maintains Neutral on Biogen, Raises Price Target to $244
• 15:31 Biogen Q3 Earnings Preview: Grounds For Optimism, But Disappointment The Norm
• 13:53 TD Cowen Maintains Buy on Biogen, Raises Price Target to $250
• 13:00 Biogen Inc. (BIIB) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
• 12:06 The Zacks Analyst Blog Highlights BridgeBio Pharma, Intellia Therapeutics, Biogen and Viking Therapeutics
• 20:33 Stocks Finish Mostly Higher on Earnings Optimism
• 20:03 S&P 500 Top Stock Gainers Today, 10/20/26 - TipRanks.com
• 15:25 Stocks Rebound on Strong Earnings and Lower Bond Yields
• 14:09 Stocks Pressured by Tech Stock Weakness and Higher Crude Oil Prices
• 13:55 富国银行维持对 Biogen 的增持评级，将目标价上调至 310 美元
• 13:55 Wells Fargo Maintains Overweight on Biogen, Raises Price Target to $310
• 13:30 4 Biotech Stocks With Promising Late-Stage Drug Pipelines to Watch Now
• 12:00 AbbVie's Neuroscience Franchise: What to Expect Ahead of Q3 Results
• 11:32 Biogen将在美国肾脏病学会肾脏周展示其肾脏病产品组合的数据及其他科学报告
• 11:32 Biogen To Demonstrate Data, Additional Scientific Presentations From Its Nephrology Portfolio At American Society Of Nephrology Kidney Week
• 12:28 Biogen Stock: The Bull Case Is Extending Beyond Alzheimer's (Rating Upgrade) (NASDAQ:BIIB)
• 20:34 Stocks Settle Mixed as Broader Market Recovers from Chip Stock Rout
• 15:27 Stock Indexes Rebound as Investors Rotate Out of Chip Stocks
• 14:18 Stocks Pressured as Chipmaker Selloff Deepens
• 12:38 Arrowhead Pharmaceuticals: ARO-MAPT Results Unlock A New Platform (NASDAQ:ARWR)
• 12:00 Why A Biotech M&A Wave May Hit This Winter
• 10:59 Biogen’s Quarterly Earnings Preview: What You Need to Know